What is a stock summary page? Click here for an overview.
Business Description
OK Biotech Co Ltd
ISIN : TW0004155007
Description
OK Biotech Co Ltd is engaged in the manufacturing of electronic materials and medical equipment. The company's products include Portable Nebulizer, Blood Glucose Meter, Glucometer, Blood Sugar Meter, Blood Glucose Test Strips, and others. Geographically, the company generates a majority of its revenue from Asia (excluding Taiwan) followed by America, Africa, Europe, and Taiwan.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.37 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 3.79 | |||||
| Interest Coverage | 6.5 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.17 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | 15.7 | |||||
| 3-Year EPS without NRI Growth Rate | 13.6 | |||||
| 3-Year FCF Growth Rate | -58.2 | |||||
| 3-Year Book Growth Rate | 1.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.69 | |||||
| 9-Day RSI | 41.89 | |||||
| 14-Day RSI | 38.64 | |||||
| 3-1 Month Momentum % | 6.14 | |||||
| 6-1 Month Momentum % | -17.33 | |||||
| 12-1 Month Momentum % | -16.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.98 | |||||
| Quick Ratio | 1.27 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 117.48 | |||||
| Days Sales Outstanding | 118.56 | |||||
| Days Payable | 60.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.76 | |||||
| Dividend Payout Ratio | 0.56 | |||||
| 3-Year Dividend Growth Rate | -37.6 | |||||
| Forward Dividend Yield % | 1.76 | |||||
| 5-Year Yield-on-Cost % | 0.43 | |||||
| 3-Year Average Share Buyback Ratio | -11.7 | |||||
| Shareholder Yield % | -3.39 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.51 | |||||
| Operating Margin % | 2.42 | |||||
| Net Margin % | 5.63 | |||||
| FCF Margin % | -18.49 | |||||
| ROE % | 3.84 | |||||
| ROA % | 2.79 | |||||
| ROIC % | 1.23 | |||||
| 3-Year ROIIC % | 2.13 | |||||
| ROC (Joel Greenblatt) % | 6.65 | |||||
| ROCE % | 4.99 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.74 | |||||
| PE Ratio without NRI | 32.27 | |||||
| Shiller PE Ratio | 13.21 | |||||
| PS Ratio | 1.51 | |||||
| PB Ratio | 1.02 | |||||
| Price-to-Tangible-Book | 1.26 | |||||
| Price-to-Operating-Cash-Flow | 42.47 | |||||
| EV-to-EBIT | 23.2 | |||||
| EV-to-EBITDA | 15.04 | |||||
| EV-to-Revenue | 1.85 | |||||
| EV-to-FCF | -9.94 | |||||
| Price-to-GF-Value | 0.59 | |||||
| Price-to-Projected-FCF | 3.09 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Price-to-Net-Current-Asset-Value | 9.4 | |||||
| Earnings Yield (Greenblatt) % | 4.31 | |||||
| FCF Yield % | -12.21 | |||||
| Forward Rate of Return (Yacktman) % | -24.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OK Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,670.033 | ||
| EPS (TTM) (NT$) | 0.62 | ||
| Beta | -0.32 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 18.49 | ||
| 14-Day RSI | 38.64 | ||
| 14-Day ATR (NT$) | 0.77725 | ||
| 20-Day SMA (NT$) | 18.94 | ||
| 12-1 Month Momentum % | -16.5 | ||
| 52-Week Range (NT$) | 13.9 - 28.2 | ||
| Shares Outstanding (Mil) | 147.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OK Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OK Biotech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
OK Biotech Co Ltd Frequently Asked Questions
What is OK Biotech Co Ltd(TPE:4155)'s stock price today?
The current price of TPE:4155 is NT$17.20. The 52 week high of TPE:4155 is NT$28.20 and 52 week low is NT$13.90.
When is next earnings date of OK Biotech Co Ltd(TPE:4155)?
The next earnings date of OK Biotech Co Ltd(TPE:4155) is .
Does OK Biotech Co Ltd(TPE:4155) pay dividends? If so, how much?
The Dividend Yield %  of OK Biotech Co Ltd(TPE:4155) is 1.76% (As of Today), Highest Dividend Payout Ratio of OK Biotech Co Ltd(TPE:4155) was 18.34. The lowest was 0.12. And the median was 0.87. The  Forward Dividend Yield % of OK Biotech Co Ltd(TPE:4155) is 1.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers